Skip to main content
GutCited

N-Acetyl Cysteine (NAC) لـ Inflammatory Bowel Disease (IBD) — General

D

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

الخلاصة

Pilot data only. Glutathione precursor may reduce oxidative stress in IBD. Requires larger clinical trials.

Key Study Findings

Review
Nanocatalytic Antioxidation: A General Chemical Approach for Alleviating Oxidative Stress in Diseases.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Review of nanocatalytic antioxidation in diseases

Randomized Controlled Trial 16 weeks Open-label
Exploring the role of oxidative stress and the effect of N-acetylcysteine in thiopurine-induced liver injury …
Dose: N-acetylcysteine with thiopurine مقابل: Thiopurine alone (crossover) Outcome: Liver injury markers and oxidative stress التأثير: None None

المجتمع المدروس: IBD patients with thiopurine-induced liver injury

Review
The emerging role of oxidative stress in inflammatory bowel disease.
Dose: None مقابل: None Outcome: Oxidative stress role in IBD pathophysiology التأثير: None None

المجتمع المدروس: IBD patients (Crohn's and UC)

In Vitro 4.3 weeks
Extraintestinal Manifestations in Induced Colitis: Controversial Effects of N-Acetylcysteine on Colon, Liver, and Kidney.
Dose: 150 mg/kg مقابل: None Outcome: inflammation markers التأثير: None None

المجتمع المدروس: Mice

Systematic Review 52 weeks
Vitamin D for the treatment of inflammatory bowel disease.
Dose: 400 IU/day مقابل: placebo Outcome: IBD disease activity التأثير: None None

المجتمع المدروس: Patients with IBD

Review
Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease …
Dose: None مقابل: None Outcome: Ferroptosis role in IBD pathogenesis التأثير: None None

المجتمع المدروس: IBD patients (mechanistic review)

Key Statistics

1

الدراسات

30

المشاركون

Positive

D

التقييم

Referenced Papers

Frontiers in endocrinology 2024 165 اقتباسات
Pharmaceuticals (Basel, Switzerland) 2023 18 اقتباسات
The Cochrane database … 2023 1 اقتباسات
European journal of … 2021 40 اقتباسات
The British journal … 2012 145 اقتباسات
The Tohoku journal … 2005 114 اقتباسات
Laboratory investigation; a … 2000 116 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
600-1,200 mg/day in divided doses
hpyloriadjunct:
600 mg twice daily alongside standard triple therapy
antioxidantsupport:
600-900 mg/day

الحد الأعلى: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Mixed --
N-acetylcysteine with thiopurine 16 weeks Positive --
None -- Positive --
150 mg/kg 4.3 weeks Positive --
400 IU/day 52 weeks Mixed --
None -- Neutral --
Various antioxidant compounds -- Positive --
None -- Mixed --

أفضل وقت للتناول: With or without food; divide doses throughout the day

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Nausea and vomiting (most common, especially at higher doses)
  • Diarrhea
  • Unpleasant sulfur taste/odor
  • Headache

التفاعلات المعروفة

  • Nitroglycerin (NAC may enhance vasodilatory effects; risk of hypotension)
  • Activated charcoal (may reduce NAC absorption)
  • Anticoagulants (NAC may have mild antiplatelet effects)
  • ACE inhibitors (additive hypotensive effect with nitroglycerin combination)

الحد الأقصى المسموح به: Generally well-tolerated up to 1,800 mg/day; higher doses used in clinical settings

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does N-Acetyl Cysteine (NAC) help with Inflammatory Bowel Disease (IBD) — General?
Based on 1 studies with 30 participants, there is preliminary evidence that needs more research that N-Acetyl Cysteine (NAC) may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is D (Very Early Research).
How much N-Acetyl Cysteine (NAC) should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-1,200 mg/day in divided doses. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetyl Cysteine (NAC)?
Reported side effects may include Nausea and vomiting (most common, especially at higher doses), Diarrhea, Unpleasant sulfur taste/odor, Headache. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetyl Cysteine (NAC) and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade D (Very Early Research). This rating is based on 1 peer-reviewed studies with 30 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Inflammatory Bowel Disease (IBD) — General

N-Acetyl Cysteine (NAC) لحالات أخرى

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.